Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleSBRT With Atezo/Bev for HCC
- Where
- Philadelphia
- Age
- 18 years to 99 years
- People
- 18
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT05488522 - Phase 1Taking peopleAtezolizumab+Bevacizumab+SBRT in Unresectable HCC
- Where
- Boston
- Age
- 18 years and over
- People
- 20
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05096715 - No phaseTaking peopleBiobank for Cholestatic Liver Diseases.
- Where
- Rochester
- Age
- 18 years to 85 years
- People
- 9,150
- Run by
- Mayo Clinic
See details and how to joinNCT03445585 - No phaseTaking peopleCharacterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
- Where
- Rochester
- Age
- 18 years to 85 years
- People
- 300
- Run by
- Mayo Clinic
See details and how to joinNCT04753996 - Phase 2Taking peopleContrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 266
- Run by
- john eisenbrey
See details and how to joinNCT06261814 - Phase 1Taking peopleImmunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
- Where
- Seattle
- Age
- 1 year to 26 years
- People
- 21
- Run by
- Seattle Children's Hospital
See details and how to joinNCT07148050 - No phaseEnrolling by invitationProject OASIS: Optimizing Approaches to Select Implementation Strategies
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 8,020
- Run by
- VA Office of Research and Development
See details and how to joinNCT06061328 - Phase 2Taking peopleStudy of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
- Where
- Lexington
- Age
- 18 years to 99 years
- People
- 80
- Run by
- Michael J Cavnar, MD
See details and how to joinNCT07201519 - No phaseTaking peopleMultilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 730
- Run by
- University of Southern California
See details and how to joinNCT07312162 - Phase 2Taking peopleCelecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer
- Where
- Atlanta
- Age
- 18 years and over
- People
- 39
- Run by
- Emory University
See details and how to joinNCT07174570 - Phase 4Enrolling by invitationSafety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
- Where
- Chicago, Dallas, Kansas City, Memphis, New York, Philadelphia, Rochester, San Francisco, St Louis
- Age
- 18 years and over
- People
- 336
- Run by
- Baylor Research Institute
See details and how to joinNCT02081755 - No phaseTaking peopleDevelopment of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
- Where
- Palo Alto, Philadelphia, San Diego
- Age
- 18 years and over
- People
- 80
- Run by
- University of California, San Diego
See details and how to joinNCT05705219 - Phase 4Taking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Boston, Chapel Hill, Chicago, Dallas, Hershey, Houston, Madison, Methuen, New Haven, Peoria, Philadelphia, Scottsdale, St Louis, Worcester
- Age
- 18 years to 64 years
- People
- 2,076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - Phase 1/2Taking peopleCabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- Where
- Pittsburgh, Westwood
- Age
- 18 years and over
- People
- 117
- Run by
- Anwaar Saeed
See details and how to joinNCT03539822 - Phase 1Taking peopleA Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
- Where
- Dallas, Fairfax, Huntersville
- Age
- 18 years and over
- People
- 270
- Run by
- Conjupro Biotherapeutics, Inc.
See details and how to joinNCT07317505 - Phase 2Taking peopleTislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
- Where
- New Brunswick, The Bronx
- Age
- 18 years and over
- People
- 35
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT05366829 - No phaseTaking peopleSample Collection for Ongoing Research and Product Evaluation Study
- Where
- Austin
- Age
- 18 years and over
- People
- 9,600
- Run by
- Natera, Inc.
See details and how to joinNCT07318051 - Phase 4Taking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- La Jolla
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - No phaseTaking peopleCharacterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
- Where
- San Antonio
- Age
- 18 years and over
- People
- 84
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT03894917 - Phase 2Taking peopleStudy of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
- Where
- San Antonio
- Age
- 18 years and over
- People
- 32
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT06526104 - No phaseTaking peopleLiquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 12
- Run by
- Palo Alto Veterans Institute for Research
See details and how to joinNCT07303712 - No phaseTaking peopleIntra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 30
- Run by
- Palo Alto Veterans Institute for Research
See details and how to joinNCT07303725 - Phase 1Taking peopleSacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
- Where
- Detroit
- Age
- 18 years and over
- People
- 20
- Run by
- Henry Ford Health System
See details and how to joinNCT06065371 - Phase 4Not yet taking people in United StatesHOPE Against Cancer Recurrence in HCC
- Where
- Cleveland, New York
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - Phase 1/2Taking peopleA Study of MT-4561 in Patients With Various Advanced Solid Tumors
- Where
- Columbus, Grand Rapids, Houston, Los Angeles
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Tanabe Pharma America, Inc.
See details and how to joinNCT06943521